New Strong Sell Stocks for June 27th

BBC
Plan for London's largest nature haven
As many as 1,000 hectares of farmland in north London could be turned into an area for public use.
BBC
Caribbean braces as Hurricane Beryl strengthens
Caribbean islands are preparing for the arrival of an increasingly powerful storm from Sunday night.
Associated Press
Wimbledon is set to start with Carlos Alcaraz, Emma Raducanu and Coco Gauff on the schedule
The 2024 edition of Wimbledon is scheduled to start on Monday, with defending champion Carlos Alcaraz and past Grand Slam title winners Coco Gauff and Emma Raducanu all set to play in matches at Centre Court. Alcaraz just won his third major championship at the French Open three weeks ago.
Yahoo News Australia
Harley Davidson rider’s surprise response to police after losing licence
The driver apparently had just three words to say after being pulled over by police for travelling more than double the speed limit.
Business Wire
HAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award
LAUSANNE, Switzerland & SAN DIEGO, July 01, 2024--HAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award for their Entrepreneurial Vision
Reuters
Airbus says to get $559 million compensation under Spirit Aero deal
Europe's Airbus on Monday set out the terms under which it plans to buy certain loss-making activities of Spirit AeroSystems as part of a planned wider break-up of the supplier between Airbus and rival Boeing. The deal involves Airbus taking over work at loss-making plants that supply key parts for its A220 and A350 passenger jets. Airbus will be compensated for agreeing to take on the work by a payment of $559 million from Spirit, while it will pay a nominal sum of $1 for the assets, depending on the final outline of the deal, it said in a statement.
Simply Wall St.
Avoid JDE Peet's And Explore One Better Dividend Option On Euronext Amsterdam
Investors often look to dividend stocks in the Netherlands for a reliable income stream. However, it's important to assess the sustainability of these dividends. For instance, companies like JDE Peet's may present a higher risk due to their high payout ratios, which could jeopardize their ability to maintain dividend payments in the long term.
Business Wire
ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
SEOUL, South Korea, July 01, 2024--ReCerise Therapeutics Inc. (CEO Yong-Bae Kim), has announced its selection for a grant from the Ministry of Trade, Industry and Energy (MOTIE) of South Korea. The grant aims to support the development of tailored targeted therapies for refractory cancer or cancer subtypes. This funding will facilitate the discovery of new drug candidates, as well as their efficacy verification and validation.
Evening Standard
London leavers: 'We sold our flat in Stoke Newington and bought a dilapidated barn in Rutland for £445k'
Lucia Paredes and Jamie Kirk traded London life for renovating a historic barn in England’s smallest county
USA TODAY
Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Monkey in the Middle
Explore daily insights on the USA TODAY crossword puzzle by Sally Hoelscher. Uncover expert takes and answers in our crossword blog.
Evening Standard
Horoscope today: Your daily guide for Monday, July 1, 2024
Read what the stars mean for you today, from Cancer to Gemini
GlobeNewswire
Corbion reports the progress of its € 20 million share buyback program 24 June – 28 June 2024
Corbion hereby reports the transaction details related to its € 20 million share buyback program announced on 26 April 2024. During the week of 24 June up to and including 28 June 2024 a total of 78,992 shares were repurchased at an average price of €18.8253 for a total amount of €1,487,045.87. To date, the total consideration for shares repurchased amounts to €16,300,457.70 representing 81.5% of the overall share buyback program. Corbion publishes on a weekly basis every Monday, an overview of
GlobeNewswire
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ®
Saint Herblain (France), July 1, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Commission (EC) has granted marketing authorization in Europe for Valneva’s single-dose vaccine, IXCHIQ®, for the prevention of disease caused by the chikungunya virus in individuals 18 years of age and older. The approval was unanimously endorsed by Member States following a stringent assessment by the European Medicines Agency (EMA)1. The EC dec
GlobeNewswire
Global Super Abrasive Market Size To Worth USD 86.54 Billion By 2033 | CAGR Of 5.88%
The Global Super Abrasive Market Size was Valued at USD 48.89 Billion in 2023 and the Worldwide Super Abrasive Market Size is Expected to Reach USD 86.54 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Sino-Crystal Diamond, 3M, Nippon Resibon Corporation, Robert Bosch GmbH, JINQU Superhard, Anhui HongJing, Deerfos, Sak Industries, Carborundum Universal Limited, Saint Gobain, Deerfos, Asahi Diamond Industrial, Fujimi Incorporated, K
GlobeNewswire
Idorsia’s JERAYGO (aprocitentan) approved in Europe as first and only ERA for the treatment of resistant hypertension
Idorsia receives approval from the European Commission (EC) for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral antihypertensive therapy – the first in almost 40 years – that is working via a new therapeutic pathway. Allschwil, Switzerland – July 1, 2024Idorsia Ltd (SIX: IDIA) announced today that the European Commission (EC) has approved JERAYGO™ (aprocitentan) for the treatment of resistant hyp
The Independent
Season’s Eatings: What to cook and eat in July
From the versatile aubergine to the sweet juiciness of peaches, discover how to select, prepare and savour these seasonal delights through an array of dishes that showcase the best of summer’s flavours
Business Wire
Elliptic Labs Signs Expansion Contract with Oppo
OSLO, Norway, July 01, 2024--Elliptic Labs has signed an expansion contract with Oppo for future smartphone launches.
Business Wire
Carmila: Potential Stake Increase in Galimmo SCA to 99.9%
PARIS, July 01, 2024--Regulatory News: On June 28, 2024, Carmila (Paris:CARM) granted to an entity managed by Primonial REIM France a put option to sell its entire 7% stake in Galimmo SCA, exercisable1 until July 30, 2024, for approximately €27 million (that is €11.93 per share).
GlobeNewswire
Addex Shareholders Approve All Resolutions at Annual General Meeting
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 1, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that its shareholders approved, with a large majority, all proposals of the board of directors in its 2024 Annual General Meeting (AGM). The votes represented 33.79% of the company's outstanding capital. Addex shareholders approved the 2023 annu
GlobeNewswire
FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US Pyzchiva® (ustekinumab-ttwe) is approved by FDA for all indications of reference medicineFDA granted provisional determination for interchangeability designation for Pyzchiva®Extends Sandoz immunology portfolio and further strengthens biosimilar position Expected to be among first wave of ustekinumab biosimilars to launch in US Basel,

NZX 50

NZD/USD

NZD/EUR

ALL ORDS

ASX 200

OIL

GOLD

NASDAQ

FTSE

Dow Jones

DAX

Hang Seng

NIKKEI 225

NZD/JPY

New Strong Sell Stocks for June 27th

Latest stories

Plan for London's largest nature haven

Caribbean braces as Hurricane Beryl strengthens

Wimbledon is set to start with Carlos Alcaraz, Emma Raducanu and Coco Gauff on the schedule

Harley Davidson rider’s surprise response to police after losing licence

HAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award

Airbus says to get $559 million compensation under Spirit Aero deal

Avoid JDE Peet's And Explore One Better Dividend Option On Euronext Amsterdam

ReCerise Therapeutics Inc. Selected for Government Project by MOTIE

London leavers: 'We sold our flat in Stoke Newington and bought a dilapidated barn in Rutland for £445k'

Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Monkey in the Middle

Horoscope today: Your daily guide for Monday, July 1, 2024

Corbion reports the progress of its € 20 million share buyback program 24 June – 28 June 2024

Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ®

Global Super Abrasive Market Size To Worth USD 86.54 Billion By 2033 | CAGR Of 5.88%

Idorsia’s JERAYGO (aprocitentan) approved in Europe as first and only ERA for the treatment of resistant hypertension

Season’s Eatings: What to cook and eat in July

Elliptic Labs Signs Expansion Contract with Oppo

Carmila: Potential Stake Increase in Galimmo SCA to 99.9%

Addex Shareholders Approve All Resolutions at Annual General Meeting

FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US